510(k) device
MOLLI 2 System
Molli Surgical, Inc. · Marker, Radiographic, Implantable (NEU, Class II) · First FDA decision Jan 18, 2023, newest Sep 26, 2024Breast cancer
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
1
Naming "MOLLI 2"
MAUDE reports
4
Brand "MOLLI 2", since 2015
PubMed studies
0
Mentioning "MOLLI 2"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MOLLI 2 System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- MOLLI 2 System510(k)
K234149 · Decided Sep 26, 2024 · 272 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- MOLLI 2 System510(k)
K240042 · Decided Sep 25, 2024 · 264 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- MOLLI 2510(k)
K231579 · Decided Oct 26, 2023 · 148 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MOLLI 2", any status and sponsor, newest update first.
Daphne KosAcademic, hospital or other
NCT07202195 · 70 participants (planned) · Start Mar 16, 2026 · Primary completion Sep 2027
Device: electro-stimulation suit · For: Multiple Sclerosis; MS (Multiple Sclerosis); Spasticity With Multiple Sclerosis and 5 more
Sites: Steenokkerzeel, Belgium; Ry, Denmark
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MOLLI 2", and for the whole product code for context.
This brand
4 reports: 1 malfunction, 3 injury, 0 death
Whole product code NEU
1,678 reports: 518 malfunction, 1,149 injury, 1 death
Newest reports for this brand
- MOLLI 2 TABLETMalfunction
3015439135-2026-00002 · Received Jun 29, 2026 · Event dated Jun 1, 2026
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Connection Problem; Intermittent Communication Failure
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- MOLLI 2 TABLETInjury
3015439135-2026-00001 · Received Jun 4, 2026 · Event dated May 12, 2026
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Connection Problem; Intermittent Communication Failure
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- MOLLI 2 WANDInjury
3015439135-2025-00003 · Received Dec 17, 2025 · Event dated Jun 14, 2025
Device type: Marker, Radiographic, Implantable (NEU)
Device problem as coded: Electromagnetic Interference
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1427-2026 · Started Jan 21, 2026 · Posted by FDA Feb 17, 2026
Reason given: Due to a need to update the product labeling (Instructions for Use IFU) as a result of the magnetized surgical tools dislodging markers using during target tissue removal procedures.
Cause as FDA categorized it: Under Investigation by firm · Device type: Marker, Radiographic, Implantable (NEU)
Published research
The most relevant PubMed records for "MOLLI 2"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NEU.
- HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 510(k) 2022
- HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape)Devicor Medical Products, Inc. · 510(k) 2026
- UltraCor Twirl Breast Tissue MarkerBard Peripheral Vascular, Inc. · 510(k) 2025
- RFID Localization SystemHealth Beacons, Inc. · 510(k) 2020
- Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. · 510(k) 2018
- Beacon Tissue Marker (SE)Scion Medical Technologies, LLC · 510(k) 2015
- Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC · 510(k) 2012
- Securmark Biopsy Site Marking SystemSuros Surgical Systems, Inc. A Hologic Company · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.